The role of single-photon emission computed tomography and SPECT/computed tomography in oncologic imaging

Seminars in Oncology

Volumn 38, Issue 1, 2011, Pages 87-108

  Brandon, David ^a,b   Alazraki, Adina ^a,c   Halkar, Raghuveer K ^a,b   Alazraki, Naomi P ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

^c CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE; (3 IODOBENZYL)GUANIDINE I 123; (3 IODOBENZYL)GUANIDINE I 131; ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIHYPERTENSIVE AGENT; ANTINEOPLASTIC AGENT; CAPROMAB PENDETIDE IN 111; CONTRAST MEDIUM; DEPREOTIDE TC 99M; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; GLUCOSE; IODINE; IODINE 123; IODINE 131; MEDRONATE TECHNETIUM TC 99M; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NEUROLEPTIC AGENT; OCTREOTIDE; PENTETREOTIDE; PENTETREOTIDE IN 111; POTASSIUM PERCHLORATE; RADIOACTIVE IODINE; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN DERIVATIVE; TECHNETIUM 99M; TRACER; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

ABDOMINAL PAIN; ARTICLE; BONE SCINTISCANNING; BRACHYTHERAPY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER THERAPY; CARCINOID; CLINICAL TRIAL (TOPIC); COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG HALF LIFE; DRUG MEGADOSE; DRUG UPTAKE; ECHO PLANAR IMAGING; EXTERNAL BEAM RADIOTHERAPY; FALSE POSITIVE RESULT; HISTOPATHOLOGY; HUMAN; HYPOGLYCEMIA; INSULINOMA; LUNG METASTASIS; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHOSCINTIGRAPHY; MOLECULAR IMAGING; MYELOMA; NEUROBLASTOMA; NEUROENDOCRINE TUMOR; NEUROIMAGING; NEUROSURGERY; ONCOLOGY; OVERALL SURVIVAL; PANCREAS ISLET CELL TUMOR; PARAGANGLIOMA; PARATHYROID ADENOMA; PARATHYROID GLAND; PERSONALIZED MEDICINE; PHARMACODYNAMICS; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSTATE CARCINOMA; QUALITY OF LIFE; RADIATION DOSE; RADIATION EXPOSURE; SECONDARY HYPERPARATHYROIDISM; SELECTIVE INTERNAL RADIATION THERAPY; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TACHYCARDIA; THYROID CANCER; THYROID CARCINOMA; THYROID MEDULLARY CARCINOMA; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR LOCALIZATION; TUMOR VOLUME; UNSPECIFIED SIDE EFFECT; VOMITING;

DRUG MONITORING; HUMANS; MOLECULAR IMAGING; NEOPLASM STAGING; NEOPLASMS; NEUROENDOCRINE TUMORS; RADIATION INJURIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79952165252     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2010.11.003     Document Type: Article

References (109)

1. C.P. Kaiser Diagnostic SPECT/CT: all in favor MolecularImaging.net, TriMed Media Group, Providence, RI [internet] [cited 2010 Feb 10] 2009 Nov 19 http://www.molecularimaging.net/index.php?option=com-articles&view= article&id=19645 diagnostic-spectct-all-in-favor
2. W. Cai, and X. Chen Multimodality molecular imaging of tumor angiogenesis J Nucl Med 49 Suppl 2 2008 S113 S128
3. Nuclear Medicine Section International Atomic Energy Agency Clinical applications of SPECT/CT: new hybrid nuclear medicine imaging system: IAEA-TECDOC-1597 2008 IAEA Vienna, Austria
4. D.J. Kwekkeboom, and E.P. Krenning Somatostatin receptor imaging Semin Nucl Med 32 2002 84 91 (Pubitemid 34311074)
5. 111In-DTPA-octreotide scintigraphy in the detection of neuroendocrine tumors. Paper presented at 49th Annual Meeting of the Society of Nuclear Medicine; 2001 June 17; Los Angeles, CA.
6. M.M. Rehani, L. Gordon, and P. Shrimpton ICRP publication 87: managing patient dose in computed tomography Ann ICRP 30 2000 1 45
7. OctreoScan package insert Revised March 1995 Mallinckrodt Medical Inc St Louis, MO
8. P. Saeed, M.W. Tanck, N. Freling, L. Baldeschi, M.P. Mourits, and R.J. Bennink Somatostatin receptor scintigraphy for optic nerve sheath meningiomas Ophthalmology 116 2009 1581 1586
9. 99mTc- depreotide in the management of neuroendocrine tumours Nucl Med Commun 29 2008 436 440 (Pubitemid 351507537)
10. J. Blum, H. Handmaker, J. Lister-James, and N. Rinne A multicenter trial with a somatostatin analog (99m)Tc depreotide in the evaluation of solitary pulmonary nodules Chest 117 2000 1232 1238 (Pubitemid 30321573)
11. R. Axelsson, G. Herlin, M. Bth, P. Aspelin, and K.G. Klbeck Role of Scintigraphy with technetium-99m depreotide in the diagnosis and management of patients with suspected lung cancer Acta Radiol 49 2008 295 302
12. P. Merlet, O. Piot, J.L. Dubois-Rand, D. Loisance, A. Castaigne, and A. Syrota Clinical use of metaiodobenzylguanidine imaging in cardiology Q J Nucl Med 39 Suppl 1 1995 29 39
13. 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review Eur Heart J 29 2008 1147 1159 (Pubitemid 351844881)
14. 123I-metaiodobenzylguanidine (MIBG) scintigraphy procedure guidelines for tumour imaging [internet]. European Association of Nuclear Medicine Guidelines [cited 2010 Feb 10] 2003 Sep 2 www.eanm.org/scientific-info/ guidelines/gl-onco-mibg.pdf
15. B.L. Shulkin, B. Shapiro, I.R. Francis, R. Dorr, S.W. Shen, and J.C. Sisson Primary extra-adrenal pheochromocytoma: positive I-123 MIBG imaging with negative I-131 MIBG imaging Clin Nucl Med 11 1986 851 854 (Pubitemid 17221351)
16. S. Tsuchimochi, M. Nakajo, Y. Nakabeppu, and A. Tani Metastatic pulmonary pheochromocytomas: positive I-123 MIBG SPECT with negative I-131 MIBG and equivocal I-123 MIBG planar imaging Clin Nucl Med 22 1997 687 690 (Pubitemid 28049449)
17. J. Bomanji, W.D. Flatman, and T. Horne Quantitation of Iodine-123 MIBG uptake by normal adrenal medulla in hypertensive patients J Nucl Med 28 1987 319 324 (Pubitemid 17049465)
18. AdreView (Iobenguane I 123 Injection) package insert Revised 2008 GE Healthcare, Medi-Physics, Inc Arlington Heights, IL
19. P. Som, H.L. Atkins, and D. Bandoypadhyay A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic tracer for rapid tumor detection J Nucl Med 21 1980 670 675 (Pubitemid 10034639)
20. K.K. Wong, J.M. Cahill, K.A. Frey, and A.M. Avram Incremental value of 111-In pentetreotide SPECT/CT fusion imaging of neuroendocrine tumors Acad Radiol 17 2010 291 297
21. O. Schillaci Functional-anatomical image fusion in neuroendocrine tumors Cancer Biother Radiopharm 19 2004 129 134 (Pubitemid 38352294)
22. I.G. Steffen, S. Mehl, and F. Heuck Attenuation correction of somatostatin receptor SPECT by integrated low-dose CT: is there an impact on sensitivity? Clin Nucl Med 34 2009 869 873
23. S. Ezziddin, T. Logvinski, and C. Yong-Hing Toxicity and outcome of I-131 MIBG therapy in adults receiving a fixed dose of 300 mCi per course [abstract] J Nucl Med 47 Suppl 1 2006 106P
24. E.J. Postema, and A.J. McEwan Radioiodinated metaiodobenzylguandine treatment of neuroendocrine tumors in adults Cancer Biother Radiopharm 24 2009 519 525
25. N.P. Alazraki, M.J. Shumate, and D.A. Kooby Neuroendocrine cancers Clinician's guide to nuclear oncology 2007 The Society of Nuclear Medicine Reston, VA 77 88
26. K.P. Koopmans, P.L. Jager, I.P. Kema, M.N. Kerstens, F. Albers, and R.P.F. Dullaart In-111 octreotide is superior to I-123 metaiodobenzylguanidine for scintigraphic detection of head and neck paragangliomas J Nucl Med 49 2008 1232 1237
27. D. Mullassery, C. Donimici, E.C. Jesudason, H.P. McDowell, and P.D. Losty Neuroblastoma: contemporary management Arch Dis Child Educ Pract Ed 94 2009 177 185
28. M.J. Gelfand Meta-Iodobenzylguanidine in Children Semin Nucl Med 23 1993 231 242
29. G.M. Brodeur, J. Pritchard, and F. Berthold Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment J Clin Oncol 11 1993 1466 1477 (Pubitemid 23228250)
30. M. Mitjavila Meta-iodobenzylguanidine in neuroblastoma: from diagnosis to therapy Nucl Med Commun 23 2002 3 4
31. B.H. Kushner Neuroblastoma: a disease requiring a multitude of imaging studies J Nucl Med 45 2004 1172 1188 (Pubitemid 47611663)
32. B. Shulkin, B. Shapiro, and R. Hutchinson Iodine-131- metaiodobenzylguanidine and bone scintigraphy for the detection of neuroblastoma J Nucl Med 33 1992 1735 1740
33. C. Colavolpe, E. Guedj, S. Cammilleri, D. Taieb, O. Mundler, and C. Coze Utility of FDG-PET/CT in the follow-up of neuroblastoma which became MIBG-negative Pediatr Blood Cancer 51 2008 828-21
34. S.G. Dubois, Y. Kalika, J.N. Lukens, G.M. Brodeur, R.C. Seeger, and J.B. Atkinson Metastatic sites in stage IV and IV-S neuroblastoma correlate with age, tumor biology, and survival J Pediatr Hematol Oncol 21 1999 181 189 (Pubitemid 30306028)
35. F. Cowie, R. Corbett, and C.T. Pinkerton Lung involvement in neuroblastoma: incidence and characteristics Med Pediatr Oncol 28 1997 429 432 (Pubitemid 27208553)
36. K.K. Matthay, H. Brisse, and D. Couanet Central nervous system metastases in neuroblastoma: radiologic, clinical, and biologic features in 23 patients Cancer 98 2003 155 165 (Pubitemid 36741138)
37. S. Sharp, and M. Gelfand Utility of SPECT/CT imaging in neuroblastoma [abstract] J Nucl Med 50 Suppl 2 2009 200
38. 18F-FDG PET in Neuroblastoma J Nucl Med 50 2009 1237 1243
39. M.J. Gelfand, A.H. Elgazzar, V.M. Kriss, P.R. Masters, and G.J. Golsch Iodine-123-MIBG SPECT versus planar imaging in chlidren with neural crest tumors J Nucl Med 35 1994 1753 1757 (Pubitemid 24346793)
40. B.L. Shulkin, R.J. Hutchinson, V.P. Castle, G.A. Yanik, B. Shapiro, and J.C. Sisson Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy Radiology 199 1996 743 750
41. R.E. Coleman, R.A. Blinder, and R.J. Jaszczak Single photon emission computed tomography (SPECT) Part II: clinical applications Invest Radiol 21 1986 1 11 (Pubitemid 16174771)
42. J. Sharma, P. Mazzaglia, and M. Milas Radionuclide imaging for hyperparathyroidism (HPT): which is the best technetium-99m sestamibi modality? Surgery 140 2006 856 863
43. P.B. Zald, B.E. Hamilton, M.L. Larsen, and J.I. Cohen The role of computed tomography for localization of parathyroid adenomas Laryngoscope 118 2008 1405 1410
44. A.Y. Chen, A. Jemal, and E.M. Ward Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005 Cancer 115 2009 3801 3807
45. 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma Eur J Nucl Med Mol Imaging 31 2004 1435 1442 (Pubitemid 39361941)
46. 131I SPECT and CT images in patients with differentiated thyroid carcinoma J Nucl Med 44 2003 1905 1910 (Pubitemid 40022135)
47. J. Ruf, L. Lehmkuhl, and H. Bertram Impact of SPECT and integrated low-dose CT after radioiodine therapy on the management of patients with thyroid carcinoma Nucl Med Commun 25 2004 1177 1182 (Pubitemid 39614278)
48. 131I SPECT/Spiral CT on nodal staging of differentiated thyroid carcinoma at the first radioablation J Nucl Med 50 2009 18 23
49. 131I SPECT/CT fusion imaging in the evaluation of differentiated thyroid carcinoma Am J Roentgenol 191 2008 1785 1794
50. 131I SPECT/CT in the follow-up of differentiated thyroid carcinoma: incremental value versus planar imaging J Nucl Med 50 2009 184 190
51. 131I SPECT/CT in the management of patients with differentiated thyroid carcinoma J Nucl Med 49 2008 1952 1957
52. 131I SPECT-CT offers high diagnostic accuracy when the findings on conventional planar imaging are inconclusive and allows a tailored patient treatment regimen Eur J Nucl Med Mol Imaging 36 2009 886 893
53. 131I-SPECT/CT at the first radioablation Eur J Nucl Med Mol Imaging 2009 Nov 20 www.springerlink.com 10.1007/s00259-009- 1299-2 Epub
54. 131I scintigraphy for thyroid cancer J Clin Endocrinol Metab 94 2009 2075 2084
55. G.L. Wright Jr, B.M. Grob, and C. Haley Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy Urology 48 1996 326 334 (Pubitemid 26279634)
56. J.K. Troyer, M.L. Beckett, and G.L. Wright Jr Location of prostate-specific membrane antigen in the LNCaP prostate carcinoma cell line Prostate 30 1997 232 242 (Pubitemid 27172834)
57. M.J. Manyak Indium-111 capromab pendetide in the management of recurrent prostate cancer Expert Rev Anticancer Ther 8 2008 175 181 (Pubitemid 351385907)
58. R.J. Hamilton, M.J. Blend, C.A. Pelizzari, B.D. Milliken, and S. Vijayakumar Using vascular structure for CT-SPECT registration in the pelvis J Nucl Med 40 1999 347 351 (Pubitemid 29077100)
59. Z. Lee, K.K. Nagano, J.L. Duerk, D.B. Sodee, and D.L. Wilson Automatic registration of MR and SPECT images for treatment planning in prostate cancer Acad Radiol 10 2003 673 684 (Pubitemid 36628917)
60. D.B. Sodee, A.E. Sodee, and G. Bakale Synergistic value of single-photon emission computed tomography/computed tomography fusion to radioimmunoscintigraphic imaging of prostate cancer Semin Nucl Med 37 2007 17 28 (Pubitemid 44854756)
61. M. Kimura, M. Tsivian, and V. Mouraviev Utilization of (111)In-Capromab pendetide SPECT-CT for detecting seminal vesicle invasion with recurrent prostate cancer after primary in situ therapy Int J Urol 16 2009 971 975
62. 111In- capromab pendetide SPECT/CT J Nucl Med 51 2010 31 36
63. Y. Seo, K.H. Wong, M. Sun, B.L. Franc, R.A. Hawkins, and B.H. Hasegawa Correction of photon attenuation and collimator response for a body-contouring SPECT/CT imaging system J Nucl Med 46 2005 868 877
64. D.B. Sodee, A.D. Nelson, P.F. Faulhaber, G.T. Maclennan, M.I. Resnick, and G. Bakale Update on fused capromab pendetide imaging of prostate cancer Clin Prostate Cancer 3 2005 230 238 (Pubitemid 40770201)
65. C.J. Schettino, E.L. Kramer, M.E. Noz, S. Taneja, P. Padmanabhan, and H. Lepor Impact of fusion of indium-111 capromab pendetide volume data sets with those from MRI or CT in patients with recurrent prostate cancer Am J Roentgenol 183 2004 519 524 (Pubitemid 38970350)
66. R.J. Ellis, H. Zhou, and E.Y. Kim Biochemical disease-free survival rates following definitive low-dose-rate prostate brachytherapy with dose escalation to biologic target volumes identified with SPECT/CT capromab pendetide Brachytherapy 6 2007 16 25 (Pubitemid 46187326)
67. R.J. Ellis, H. Zhou, and D.A. Kaminsky Rectal morbidity after permanent prostate brachytherapy with dose escalation to biologic target volumes identified by SPECT/CT fusion Brachytherapy 6 2007 149 156 (Pubitemid 46551965)
68. R.J. Ellis, E.H. Zhou, and P. Fu Single photon emission computerized tomography with capromab pendetide plus computerized tomography image set co-registration independently predicts biochemical failure J Urol 179 2008 1768 1773
69. M.K. Haseman, S.A. Rosenthal, S.L. Kipper, J.R. Trout, and M.J. Manyak Central abdominal uptake of indium-111 capromab pendetide (ProstaScint) predicts for poor prognosis in patients with prostate cancer Urology 70 2007 303 308 (Pubitemid 47362258)
70. M.K. O'Conner, M.L. Brown, J.C. Hung, and R.J. Hayostek The art of bone scintigraphytechnical aspects J Nucl Med 32 1991 2332 2341
71. A. Bockisch, L.S. Freudenberg, D. Schmidt, and T. Kuwert Hybrid imaging by SPECT/CT and PET-CT: proven outcomes in cancer imaging Semin Nucl Med 39 2009 276 289
72. M. Horger, S.M. Eschmann, and C. Pfannenberg Evaluation of combined transmission and emission tomography for classification of skeletal lesions Am J Roentgenol 183 2004 655 661
73. D. Utsunomiya, S. Shiraishi, and M. Imuta Added value of SPECT/CT fusion in assessing suspected bone metastasis: comparison with scintigraphy alone and nonfused scintigraphy and CT Radiology 238 2006 264 271 (Pubitemid 43010604)
74. W. Rmer, A. Nmayr, M. Uder, W. Bautz, and T. Kuwert SPECT-guided CT for evaluating foci of increased bone metabolism classified as indeterminate on SPECT in cancer patients J Nucl Med 47 2006 1102 1106 (Pubitemid 47544905)
75. H. Schirrmeister Detection of bone metastases in breast cancer by positron emission tomography Radiol Clin North Am 45 2007 669 676 (Pubitemid 47238392)
76. P. Shie, R. Cardarelli, D. Brandon, W. Erdman, and N. Abdulrahim Meta-analysis: comparison of F-18 fluorodeoxyglucose-positron emission tomography and bone scintigraphy in the detection of bone metastases in patients with breast cancer Clin Nucl Med 33 2008 97 101
77. G. Gnanasegaran, G. Cook, K. Adamson, and I. Fogelman Patterns, variants, artifacts, and pitfalls in conventional radionuclide bone imaging and SPECT/CT Semin Nucl Med 39 2009 380 395
78. H. Lerman, U. Metser, G. Lievshitz, F. Sperber, S. Shneebaum, and E. Even-Sapir Lymphoscintigraphic sentinel node identification in patients with breast cancer Eur J Nucl Med Mol Imaging 33 2006 329 337
79. I.M. van der Ploeg, R.A. Valdes Olmos, O.E. Nieweg, E.J. Rutgers, B.B. Kroon, and C.A. Hoefnagel The additional value of SPECT/CT in lymphatic mapping in breast cancer and melanoma J Nucl Med 48 2007 1756 1760 (Pubitemid 350099318)
80. B. Krug, R. Crott, M. Lonneux, J.F. Baurain, A.S. Pirson, and T. Vander Borght Role of PET in the initial staging of cutaneous malignant melanoma: systematic review Radiology 249 2008 836 844
81. R. Peare, R.T. Staff, and S.D. Heys The use of FDG-PET in assessing axillary lymph node status in breast cancer: a systematic review and meta-analysis of the literature Breast Cancer Res Treat 2010 Feb 7, 10.1007/s10549-010-0771-9 Epub www.springerlink.com
82. I.M. van der Ploeg, R.A. Olmos, B.B. Kroon, E.J. Rutgers, and O.E. Nieweg The hidden sentinel node and SPECT/CT in breast cancer patients Eur J Nucl Med Mol Imaging 36 2009 6 11
83. H. Lerman, G. Lievshitz, O. Zak, U. Metser, S. Schneebaum, and E. Even-Sapir Improved sentinel node identification by SPECT/CT in overweight patients with breast cancer J Nucl Med 48 2007 201 206 (Pubitemid 47555344)
84. K.T. Pittman Sentinel node localization in head and neck tumors Semin Nucl Med 35 2005 253 256
85. P. Payoux, C. Dekeister, R. Lopez, F. Lauwers, J.P. Esquerr, and J.R. Paoli Effectiveness of lymphoscintigraphic sentinel node detection for cervical staging of patients with squamous cell carcinoma of the head and neck J Oral Maxillofac Surg 63 2005 1091 1095 (Pubitemid 41040376)
86. E. Even-Sapir, H. Lerman, and G. Lievshitz Lymphoscintigraphy for sentinel node mapping using a hybrid SPECT/CT system J Nucl Med 44 2003 1413 1420 (Pubitemid 39663353)
87. A. Wagner, K. Schicho, and C. Glaser SPECT-CT for topographic mapping of sentinel lymph nodes prior to gamma probe-guided biopsy in head and neck squamous cell carcinoma J Craniomaxillofac Surg 32 2004 343 349 (Pubitemid 40045634)
88. R. Lopez, P. Payoux, P. Gantet, J.P. Esquerr, F. Boutault, and J.R. Paoli Multimodal image registration for localization of sentinel nodes in head and neck squamous cell carcinoma J Oral Maxillofac Surg 62 2004 1497 1504 (Pubitemid 39573241)
89. A. Khafif, S. Schneebaum, and D.M. Fliss Lymphoscintigraphy for sentinel node mapping using a hybrid single photon emission CT (SPECT)/CT system in oral cavity squamous cell carcinoma Head Neck 28 2006 874 879 (Pubitemid 44497862)
90. I.M. van der Ploeg, R.A. Valdes Olmos, and B.B. Kroon The yield of SPECT/CT for anatomic lymphatic mapping in patients with melanoma Ann Surg Oncol 16 2009 1537 1542
91. A. Sherif, U. Garske, M. de la Torre, and M. Thrn Hybrid SPECT-CT: an additional technique for sentinel node detection of patients with invasive bladder cancer Eur Urol 50 2006 83 91 (Pubitemid 43850119)
92. W.J. Zhang, R. Zheng, L.Y. Wu, X.G. Li, B. Li, and S.Z. Chen Clinical application of sentinel lymph node detection to early stage cervical cancer Ai Zheng 25 2006 224 228
93. N. Pandit-Taskar, M.L. Gemignani, A. Lyall, S.M. Larson, R.R. Barakat, and N.R. Abu Rustum Single photon emission computed tomography SPECT-CT improves sentinel node detection in cervical and uterine malignancy Gynecol Oncol 2010 Jan 29, 10.1016/j.ygyno.2009.12.021 Epub www.sciencedirect.com
94. H. Kizu, T. Takayam, and M. Fukuda Fusion of SPECT and multidetector CT images for accurate localization of pelvic sentinel lymph nodes in prostate cancer patients J Nucl Med Technol 33 2005 78 82 (Pubitemid 44783742)
95. W. Kim, Y. Menda, J. Willis, T.B. Bartel, and M.M. Graham Use of lymphoscintigraphy with SPECT/CT for sentinel node localization in a case of vaginal melanoma Clin Nucl Med 31 2006 201 202 (Pubitemid 44310035)
96. D.Y. Kim, D.S. Kwon, R. Salem, C.K. Ma, and M.S. Abouljoud Successful embolization of hepatocelluar carcinoma with yttrium-90 glass microspheres prior to liver transplantation J Gastrointest Surg 10 2006 413 416 (Pubitemid 43303837)
97. I. Taylor, R. Bennett, and S. Sherriff The blood supply of colorectal liver metastases Br J Cancer 39 1979 749 756
98. A. Townsend Selective internal radiation therapy for liver metastases from colorectal cancer Cochrane Database of Syst Rev 4 2009 CD007045
99. B. Gray, G. Van Hazel, and M. Hope Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer Ann Oncol 12 2001 1711 1720 (Pubitemid 34105661)
100. G. Van Hazel, A. Blackwell, L. Anderson, D. Price, P. Moroz, and G. Bower Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer J Surg Oncol 88 2004 78 85 (Pubitemid 39536508)
101. E. Garin, Y. Rolland, and E. Boucher First experience of hepatic radioembolization using microspheres labelled with yttrium-90 (TheraSphere): practical aspects concerning its implementation Eur J Nucl Med Mol Imaging 2009 Oct. 10, 10.1007/s00259-009-1279-6 Epub www.springerlink.com
102. 90Y microspheres in patients with hepatocellular cancer J Nucl Med 50 2009 688 692
103. T. Denecke, R. Ruhl, and B. Hildebrandt Planning transarterial radioembolization of colorectal liver metastases with yttrium 90 microspheres: evaluation of a sequential diagnostic approach using radiologic and nuclear medicine imaging techniques Eur Radiol 18 2008 892 902
104. N. Tehranipour, A. AL-Nahhas, and R. Canelo Concordant F-18 FDG PET and Y-90 bremsstrahlung scans depict selective delivery of Y-90-microspheres to liver tumors: confirmation with histopathology Clin Nucl Med 32 2007 371 374 (Pubitemid 46659171)
105. National Council of Radiation Protection and Measurements Ionizing exposure of the population of the United States (NCRP Report No 160) 2009 National Council of Radiation Protection and Measurements Bethesda, MD
106. M.K. O'Connor, and B.J. Kemp Single photon emission computed tomography: basic instrumentation and innovations Semin Nucl Med 36 2006 258 266 (Pubitemid 44300996)
107. R.D. Neumann, and D.A. Bluemke Tracking radiation exposure from diagnostic imaging devices at the NIH J Am Coll Radiol 7 2010 87 89
108. Center for Devices and Radiological Health, US Food and Drug Administration Initiative to reduce unnecessary radiation exposure from medical imaging [internet] 2010 Feb 9 [cited 2010 Feb 10] www.fda.gov. RadiationEmittingProducts/RadiationSafety/RadiationDoseReduction/ucm199994.htm
109. O. Schillaci, L. Filippi, C. Manni, and R. Santoni Single photon emission computed tomography/computed tomography in brain tumors Semin Nucl Med 37 2007 34 47 (Pubitemid 44854759)